Is Clarivate Plc (CLVT) a Buy, Sell, or Hold?
NYSE : CLVT
Clarivate Plc
$2.04 USD
$0.1 (5.15%)
- Volume
- 4.58M
- Average Volume
- 6.71M
- Market Capitalization
- $1.3B
- P/E Ratio
- -9.70
- Dividend Yield
- 0.00%
- Price Target
- $2.50
- Year High
- $4.77
- Year Low
- $1.66
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $0.84
Company Overview
NYSE
Matitiahu Shem Tov
Information Technology Services
Technology
CLVT
12000
GB
USD
Liquidity Metrics
0.91
0.84
0.84
0.15
0.00
Sales & Valuation
$2.46B
0.53
0.27
2.18
0.93
Profitability
-$0.3
-$201.1M
-5.62%
-5.62%
-2.81%
-1.26%
P/E Metrics
-9.70
-0.05
-0.05
Analyst Price Target & Rating
$2.50
$2.50
$2.50
2/5
20 Analysts
-18.40%
Financial Health Scores
-0.60
6/9
-$241M
$10.93B
$6.14B
$172.7M
Key Metrics (TTM)
$5.41B
2.21
5.82
0.84
-2.81%
1.30%
-10.51%
45.79%
71 days
Company Executives
| Name | Title |
|---|---|
| Maroun S. Mourad | Advisor |
| Matitiahu Shem Tov | Chief Executive Officer & Director |
| Bar Veinstein | President of Academia & Government |
| Henry Levy | President of Life Sciences & Healthcare |
| Jonathan Collins | Executive Vice President & Chief Financial Officer |
| Darien Krimmert | Senior Vice President & Head of People |
| Gwenan White | Senior Vice President of Communications & Brand |
| Tabita Andersson | Senior Vice President of Communications & Brand |
| William E. Graff | Executive Vice President & Chief Information Officer |
| John Doulamis | Senior Vice President & General Counsel |
| Michael Easton | Senior Vice President of Finance & Chief Accounting Officer |
| Mark J. Donohue | Head of Investor Relations |
Poll Results
No votes yet today — be the first to share your view!
About Clarivate Plc (NYSE:CLVT) Stock
Clarivate Plc operates as a prominent information services and analytics firm, furnishing structured data and insights. Its core mission is to facilitate the discovery, safeguard the intellectual property, and enable the commercialization of scientific research, innovations, and established brands. The company's portfolio includes the extensive Web of Science suite, a collection of essential tools such as Web of Science, InCites, Journal Citation Reports, EndNote, ScholarOne, Converis, Publons, and Kopernio. These are designed to support organizations throughout the entire research lifecycle, from initial planning and funding to execution and utilization. Within the Life Sciences domain, Clarivate provides specialized products like Cortellis and Newport Integrity. These platforms cater to ... pharmaceutical and biotechnology companies, empowering their research endeavors, supplying vital market intelligence, and facilitating competitive monitoring during the development and launch phases of novel drugs. Its Derwent product line, comprising Derwent Innovation, Techstreet, and IP Professional Services, is dedicated to intellectual property management. These tools enable customers to evaluate the originality of potential products, establish their freedom to operate within design parameters, secure patent protection, analyze the competitive technological landscape, and ensure adherence to essential industry standards. Complementing these, CompuMark delivers trademark screening, search, and monitoring solutions vital for businesses and legal firms. Meanwhile, MarkMonitor empowers enterprises to establish, manage, optimize, and fortify their digital presence. Clarivate's diverse clientele spans government agencies, academic institutions, life science enterprises, and research and development corporations worldwide, with operations across the Americas, Middle East, Africa, Europe, and Asia Pacific regions. The company, initially known as Clarivate Analytics Plc, rebranded to Clarivate Plc in May 2020. It maintains its headquarters in London, United Kingdom.
Clarivate RiskMark Wins 2026 CODiE Award for Best AI Tool for Lawyers
2026-07-20 03:00:00
Prestigious awards program recognizes innovative AI technology transforming trademark risk assessment for legal professionals LONDON, July 20, 2026 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a leading global provider of transformative intelligence, today announced that RiskMark has been named the winner of the 2026 CODiE Award for Best AI Tool for Lawyers. The award recognizes AI-driven solutions that significantly enhance the efficiency, accuracy and capabilities of legal professionals through advanced technology.
USPTO Launches AI Image Search in Trademark Search System, Powered by Clarivate
2026-07-16 03:00:00
LONDON, July 16, 2026 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a leading global provider of transformative intelligence, is proud to support the U.S. Patent and Trademark Office (USPTO) in launching an AI assisted image search within its public trademark search system, TM Search. This new capability allows users to upload and compare images against the U.S. trademark register and has been selected and awarded a contract by the USPTO.
Clarivate Selected by Abes to Modernize French National Academic Library System
2026-07-14 03:02:00
New cloud-based, shared and scalable platform based on Alma, Primo and Rapido creates a unified library experience Library services, resource sharing and AI-powered discovery in one platform LONDON, July 14, 2026 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, announced today that the Bibliographic Agency for Higher Education (Abes) has selected the company to modernize France's national academic library system, under a multi-year agreement. Abes supports higher education and research institutions across France with a documentation system including shared library data and services.
Clarivate to Sell Life Sciences Unit to Altaris for $600M, Refocus Core Business
2026-07-12 01:02:26
Clarivate NYSE: CLVT said it has reached an agreement to sell substantially all of its Life Sciences & Healthcare segment to Altaris, an investment firm focused on the healthcare industry, in a transaction valued at $600 million.
Clarivate to Report Second Quarter 2026 Results on July 29, 2026
2026-07-10 08:00:00
LONDON, July 10, 2026 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a leading global provider of transformative intelligence, today announced it will report its financial results for the second quarter 2026 before the market opens on Wednesday, July 29, 2026. The press release and earnings supplement, with accompanying financial information, will be available on the Clarivate investor website at https://ir.clarivate.com.
Clarivate Plc (CLVT) M&A Call Transcript
2026-07-06 12:02:26
Clarivate Plc (CLVT) M&A Call Transcript
Clarivate Announces Sale of Life Sciences & Healthcare Segment for $600 Million
2026-07-06 06:00:00
Transaction sharpens company's focus on AI-driven transformative intelligence for its leading Academia & Government and Intellectual Property segments Enhances financial profile by improving revenue mix, expanding Adjusted EBITDA margin and lowering capital intensity; proceeds to be used to reduce debt Reaffirms full-year 2026 financial outlook Conference call and webcast scheduled for 9:00 AM eastern time LONDON, July 6, 2026 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT) ("Clarivate" or the "Company"), a leading global provider of transformative intelligence, today announced it has entered into a definitive agreement to divest its Life Sciences & Healthcare ("LS&H") segment to Altaris LLC, an investment firm with an exclusive focus on acquiring and building companies in the healthcare industry, for $600 million. Following the close of the transaction, Clarivate will be a subscription-first global provider of intelligence solutions, workflow software and tech-enabled services for its leading Academia & Government ("A&G") and Intellectual Property ("IP") segments.
Clarivate Releases 2025 Sustainability Report
2026-06-23 03:00:00
New report highlights progress against goals and a decline in total carbon emissions LONDON, June 23, 2026 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, today released its 2025 Sustainability Report, highlighting continued progress against its sustainability goals, including reduction of total reported greenhouse gas emissions by 24%. Clarivate partners with 45,000 organizations worldwide, including universities, research institutions, corporations, law firms, government agencies and life science and healthcare companies to address global challenges.
Frequently Asked Questions
-
What is the current Clarivate Plc (CLVT) stock price?
-
Clarivate Plc(NYSE:CLVT) stock price is $2.04 in the last trading session. During the trading session, CLVT stock reached the peak price of $4.77 while $1.66 was the lowest point it dropped to. The percentage change in CLVT stock occurred in the recent session was 5.15% while the dollar amount for the price change in CLVT stock was $0.1.
-
CLVT's industry and sector of operation?
-
The NYSE listed CLVT is part of Information Technology Services industry that operates in the broader Technology sector.
-
Who are the executives of CLVT?
-
Maroun S. Mourad | Advisor
Matitiahu Shem Tov | Chief Executive Officer & Director
Bar Veinstein | President of Academia & Government
Henry Levy | President of Life Sciences & Healthcare
Jonathan Collins | Executive Vice President & Chief Financial Officer -
How many employees does CLVT have?
-
Number of CLVT employees currently stands at 12000. CLVT operates from 70 St. Mary Axe, London, GL EC3A 8BE, GB.
-
Link for CLVT official website?
-
Official Website of CLVT is: https://www.clarivate.com
-
How do I contact CLVT?
-
CLVT could be contacted at phone #44 20 7433 4000 and can also be accessed through its website. CLVT operates from 70 St. Mary Axe, London, GL EC3A 8BE, GB.
-
How many shares of CLVT are traded daily?
-
The average number of CLVT shares traded daily for last 3 months was 6.71M.
-
What is the market cap of CLVT currently?
-
The market value of CLVT currently stands at $1.3B with its latest stock price at $2.04